These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3764128)

  • 1. [Prognosis of generalized scleroderma. A retrospective study of 78 cases].
    Gouet D; Azaïs I; Maréchaud R; Alcalay M; Barrière H; Bontoux D; Sudre Y
    Rev Med Interne; 1986 May; 7(3):233-41. PubMed ID: 3764128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.
    Shalev T; Haviv Y; Segal E; Ehrenfeld M; Pauzner R; Levy Y; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(4):380-6. PubMed ID: 16956427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and prognostic factors in Spanish patients with systemic sclerosis.
    Simeón CP; Armadans L; Fonollosa V; Solans R; Selva A; Villar M; Lima J; Vaqué J; Vilardell M
    Rheumatology (Oxford); 2003 Jan; 42(1):71-5. PubMed ID: 12509616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of survival in systemic sclerosis (scleroderma).
    Altman RD; Medsger TA; Bloch DA; Michel BA
    Arthritis Rheum; 1991 Apr; 34(4):403-13. PubMed ID: 1901491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis. Short- and Long-Term Outcomes.
    Crespo MM; Bermudez CA; Dew MA; Johnson BA; George MP; Bhama J; Morrell M; D'Cunha J; Shigemura N; Richards TJ; Pilewski JM
    Ann Am Thorac Soc; 2016 Jun; 13(6):784-92. PubMed ID: 26669584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
    Lomeo RM; Cornella RJ; Schabel SI; Silver RM
    Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic sclerosis in men].
    Gaultier JB; Hot A; Cathébras P; Grange C; Ninet J; Rousset H
    Rev Med Interne; 2008 Mar; 29(3):181-6. PubMed ID: 17976873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
    Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
    Hoffmann-Vold AM; Tennøe AH; Garen T; Midtvedt Ø; Abraityte A; Aaløkken TM; Lund MB; Brunborg C; Aukrust P; Ueland T; Molberg Ø
    Chest; 2016 Aug; 150(2):299-306. PubMed ID: 26997242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting development of renal involvement in progressive systemic sclerosis.
    Steen VD; Medsger TA; Osial TA; Ziegler GL; Shapiro AP; Rodnan GP
    Am J Med; 1984 May; 76(5):779-86. PubMed ID: 6372452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
    Schachna L; Medsger TA; Dauber JH; Wigley FM; Braunstein NA; White B; Steen VD; Conte JV; Yang SC; McCurry KR; Borja MC; Plaskon DE; Orens JB; Gelber AC
    Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
    Fransen J; Popa-Diaconu D; Hesselstrand R; Carreira P; Valentini G; Beretta L; Airo P; Inanc M; Ullman S; Balbir-Gurman A; Sierakowski S; Allanore Y; Czirjak L; Riccieri V; Giacomelli R; Gabrielli A; Riemekasten G; Matucci-Cerinic M; Farge D; Hunzelmann N; Van den Hoogen FH; Vonk MC
    Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE; Almodovar R; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.
    Peters-Golden M; Wise RA; Hochberg MC; Stevens MB; Wigley FM
    Am J Med; 1984 Dec; 77(6):1027-34. PubMed ID: 6507456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.